Ensign Group vs Surgery Partners
Ensign Group reported revenue of $5.1 billion in fiscal 2025, 1.5 times Surgery Partners' $3.3 billion in fiscal 2025. Ensign Group's revenue grew 18.7% in its latest year, and Surgery Partners' grew 6.2%. Ensign Group had an operating margin of 8.4%, against 11.8% at Surgery Partners.
Side by side
| Ensign Group | Surgery Partners | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $5.1B | $3.3B |
| Revenue growth | 18.7% | 6.2% |
| Revenue growth a year, last 5 years | 16.1% | 12.2% |
| Gross margin | 20.5% | — |
| Operating margin | 8.4% | 11.8% |
| Net margin | 6.8% | −2.4% |
| Free cash flow | — | $196M |
| Free cash flow margin | — | 5.9% |
| Return on capital | 19.7% | 4.2% |
| Net debt to EBITDA | −0.8x | 7.8x |
| Dividends and buybacks | $34M | $0M |
| Change in diluted share count | 1.1% | 0.9% |
| Last close | $188.41 | $26.95 |
| P/E at the last close | 28.0× | — |
| Insider trades, last 12 months | sold $8.3 million | bought $143,500, sold $1.3 million |
| Piotroski F-score | 6 of 9 | 4 of 8 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Ensign GroupSurgery Partners
Operating margin
Percent of revenue
Ensign GroupSurgery Partners
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Ensign GroupSurgery Partners
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Ensign Group and Surgery Partners pages.